Blue Cross Insurers To Create Their Own Drug Company Amid Price Fight

  • 📰 Forbes
  • ⏱ Reading Time:
  • 33 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 53%

日本 ニュース ニュース

日本 最新ニュース,日本 見出し

Blue Cross and Blue Shield health insurers are launching their own nonprofit drug company with Civica Rx to create alternatives to “high-cost” generics that haven’t come down in price.

and seven hospital systems, Civica now represents more than 1,200 U.S. hospitals that say they are already benefitting from lower cost injectable drugs including antibiotics once in short supply.

Many of these same Blue Cross and Blue Shield plans already own their own pharmacy benefit management company inor use the Express Scripts PBM owned by Cigna or CVS Health’s Caremark PBM. These PBMs work as middlemen of sorts to buy drugs in bulk from manufacturers and wholesalers and leverage their clout to get better deals on prescriptions for consumers, patients and health plan customers.

The Blue Cross plans have yet to disclose which generic drugs they plan to develop first but one likely target could be insulin, which continues to have a price tag frustrating health plans even though it remains available as a generic.

このニュースをすぐに読めるように要約しました。ニュースに興味がある場合は、ここで全文を読むことができます。 続きを読む:

 /  🏆 394. in JP
 

コメントありがとうございます。コメントは審査後に公開されます。

As long as the quality is there in the generic... I feel sorry tho for people on multiple pills who only track them by color & shape. Hopefully electronic records can be accessed by hospitals whose health professionals have no way of recognizing all the different generics.

The vessel keeps shifting course...Will we ever sail calm waters?

My cousins 😂😂😭🙏😍🙏😍

日本 最新ニュース, 日本 見出し